en

PRODUCT DETAIL

Voriconazole Fresenius Kabi 200 mg prášok na infúzny roztok

Code 7235B
MA number 26/0513/15-S
Product Form: plv ifo 20x200 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AC Triazole and tetrazole derivatives
J02AC03 Voriconazole
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 21.12.2015
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Voriconazole Fresenius Kabi 200 mg plv ifo_05.2024.pdf  
SPC: SPC_Voriconazole Fresenius Kabi 200 mg plv ifo_05.2024.pdf  
Safety feature Yes
Data update: 19.05.2020
eu-flag.png sk-flag.png